(Q52180615)

26 April 2018

review article

1 reference

title

Attention-deficit disorder. A paradigm for psychotropic medication intervention in pediatrics. (English)

1 reference

26 April 2018

1 reference

S L Block

1

1 reference

26 April 2018

publication date

1 October 1998

1 reference

26 April 2018

Pediatric Clinics of North America

published in

1 reference

26 April 2018

volume

45

1 reference

26 April 2018

issue

5

1 reference

26 April 2018

page(s)

1053-1083

1 reference

26 April 2018

The role of the school in the management of attention deficit hyperactivity disorder

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970062-6

DSM-III disorders in preadolescent children. Prevalence in a large sample from the general population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970062-6

Toward a broader definition of the age-of-onset criterion for attention-deficit hyperactivity disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970062-6

Behavioral and cognitive subtypes of ADHD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970062-6

A review of stimulant drug research with hyperactive children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970062-6

Gender and comorbid psychopathology in adolescents with alcohol dependence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970062-6

Is ADHD a risk factor for psychoactive substance use disorders? Findings from a four-year prospective follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970062-6

Sustained release methylphenidate: pharmacokinetic studies in ADDH males

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970062-6

Stimulant medication and attention deficit-hyperactivity disorder. The child's perspective.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970062-6

Male testosterone linked to high social dominance but low physical aggression in early adolescence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970062-6

Training parents of hyperactive children in child management: a comparative outcome study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970062-6

Using psychostimulants to treat behavioral disorders of children and adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970062-6

Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970062-6

Patterns of comorbidity associated with subtypes of attention-deficit/hyperactivity disorder among 6- to 12-year-old children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970062-6

Drug treatment for hyperactive children. Therapeutic guidelines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970062-6

Methylphenidate and dextroamphetamine treatments of hyperactivity: are there true nonresponders?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970062-6

Gilles de la Tourette's syndrome: effects of stimulant drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970062-6

Gender differences in ADHD: a meta-analysis and critical review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970062-6

Long-term stimulant treatment of children with attention-deficit hyperactivity disorder symptoms. A randomized, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970062-6

Prevalence and implications of attention-deficit hyperactivity disorder among adolescents in treatment for substance abuse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970062-6

Comorbidity in ADHD: implications for research, practice, and DSM-V.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970062-6

Evolution and revolution in child psychiatry: ADHD as a disorder of adaptation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970062-6

Medication for children with attention disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970062-6

Attention deficits in school-aged children and adolescents. Current issues and practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970062-6

Pediatricians' knowledge and attitudes concerning diagnosis and treatment of attention deficit and hyperactivity disorders. A national survey approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970062-6

Persistence of hyperactivity symptoms from childhood to adolescence and associated outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970062-6

Validity of the age-of-onset criterion for ADHD: a report from the DSM-IV field trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970062-6

Attention-deficit hyperactivity disorder. Management by family physicians.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970062-6

Psychiatric comorbidity in patients with attention deficit disorder: a controlled study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970062-6

External validation of oppositional disorder and attention deficit disorder with hyperactivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970062-6

Imipramine and methylphenidate treatments of hyperactive boys. A double-blind comparison

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970062-6

Another sudden death in a child treated with desipramine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970062-6

Absence of tolerance to the behavioral effects of methylphenidate in hyperactive and inattentive children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970062-6

Pharmacodynamics of pemoline in attention deficit disorder with hyperactivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970062-6

Gender differences in children with ADHD, ODD, and co-occurring ADHD/ODD identified in a school population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970062-6

Three-year multimodality treatment study of 100 hyperactive boys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970062-6

Therapeutic Interventions to Prevent Delinquency in Hyperactive Boys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970062-6

The characteristics of situationally and pervasively hyperactive children: implications for syndrome definition.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970062-6

7 January 2021

Learning disabilities

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970062-6

The prevalence of attention deficit disorders in a rural midwestern community sample of nine-year-old children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970062-6

Is self-esteem an important outcome in hyperactive children?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970062-6

Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970062-6

Ontario Child Health Study: prevalence of attention deficit disorder with hyperactivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970062-6

Nortriptyline in the treatment of ADHD: a chart review of 58 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970062-6

Ineffectiveness of imipramine in children who fail to respond to methylphenidate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970062-6

Comparison of diagnostic criteria for attention-deficit hyperactivity disorder in a county-wide sample

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970062-6

Temperament issues in the school-aged child

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970062-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0031-3955(05)70062-6

1 reference

26 April 2018

1 reference

26 April 2018